However, these SSRI antidepressant effects might not depend on IDO-mediated serum tryptophan reduction, and studies of the effect of IDO inhibitors (Yuan et al, 1998) on cancer-related QoL deterioration would be needed to confirm the mechanism suggested by the present findings. Here, IDO1 is linked to cancer.